Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
89.82
-0.96 (-1.06%)
At close: Oct 12, 2026, 4:00 PM EDT
89.08
-0.74 (-0.83%)
After-hours: Oct 12, 2026, 4:05 PM EDT
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $6.18 billion as of October 12, 2026. It is the 3,109th most valuable company in the world and the 999th biggest in the United States. Its market cap has decreased by 7.65% in one year.
Market Cap
6.18B
Enterprise Value
5.96B
1-Year Change
-7.65%
Global Rank
Country Rank
#999 United States
Category
ChartMarket Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $6.18B, an increase of 659.83%. That is a compound annual growth rate of 25.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 6.18B | -13.43% |
| Dec 31, 2025 | 7.14B | 107.63% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
| Oct 5, 2017 | 813.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 6.62B |
| Immunovant | 6.29B |
| Kodiak Sciences | 6.26B |
| Belite Bio | 6.22B |
| Ligand Pharmaceuticals | 6.02B |
| CG Oncology | 5.66B |
| Erasca | 5.61B |
| Mirum Pharmaceuticals | 5.58B |